A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development

Human tuberculosis remains a significant cause of mortality and morbidity throughout the world. The global economic impact of bovine TB is considerable. An effective vaccine would be the most cost-effective way to control both epidemics, particularly in emerging economies. TB vaccine research would...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Pepponi, I, Khatri, B, Tanner, R, Villarreal-Ramos, B, Vordermeier, M, McShane, H
Natura:	Journal article
Pubblicazione:	Elsevier 2017

Documenti analoghi

The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
di: Brennan, M, et al.
Pubblicazione: (2017)

Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
di: Tanner, R, et al.
Pubblicazione: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
di: Tanner, R, et al.
Pubblicazione: (2021)

The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells [version 2; peer review: 2 approved]
di: Rachel Tanner, et al.
Pubblicazione: (2021-09-01)

Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
di: Painter, H, et al.
Pubblicazione: (2024)

Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates
di: Tanner, R
Pubblicazione: (2015)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
di: Tanner, R, et al.
Pubblicazione: (2020)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
di: Painter, H, et al.
Pubblicazione: (2024)

Development and application of the direct mycobacterial growth inhibition assay: a systematic review
di: Hannah Painter, et al.
Pubblicazione: (2024-02-01)

A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
di: McShane, H, et al.
Pubblicazione: (2016)

The humoral immune response to BCG vaccination
di: Tanner, R, et al.
Pubblicazione: (2019)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
di: Mcshane, H, et al.
Pubblicazione: (2017)

Evaluating the effect of BCG vaccination on a whole-blood mycobacterial growth inhibition assay (BACTEC MGIT)
di: Tanner, R, et al.
Pubblicazione: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
di: Marsay, L, et al.
Pubblicazione: (2013)

The Humoral Immune Response to BCG Vaccination
di: Rachel Tanner, et al.
Pubblicazione: (2019-06-01)

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays
di: Tanner, R, et al.
Pubblicazione: (2017)

Towards new TB vaccines
di: Brazier, B, et al.
Pubblicazione: (2020)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
di: Marsay, L, et al.
Pubblicazione: (2013)

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
di: Tanner, R, et al.
Pubblicazione: (2019)

Evaluating the sensitivity of the bovine BCG challenge model using a prime boost Ad85A vaccine regimen
di: Biffar, L, et al.
Pubblicazione: (2019)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
di: Dean, G, et al.
Pubblicazione: (2014)

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.
di: Fletcher, H, et al.
Pubblicazione: (2013)

TB vaccines in clinical development
di: Ginsberg, AM, et al.
Pubblicazione: (2016)

A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity
di: Emil Joseph Vergara, et al.
Pubblicazione: (2024-07-01)

In vitro Mycobacterial Growth Inhibition in South Korean Adults With Latent TB Infection
di: Hyejon Lee, et al.
Pubblicazione: (2019-04-01)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
di: Painter, H, et al.
Pubblicazione: (2020)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
di: Vordermeier, H, et al.
Pubblicazione: (2009)

Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells
di: Hannah Painter, et al.
Pubblicazione: (2020-02-01)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
di: Villarreal-Ramos, B, et al.
Pubblicazione: (2017)

Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
di: O'Shea, M, et al.
Pubblicazione: (2018)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
di: Dean, G, et al.
Pubblicazione: (2014)

A review of clinical models for the evaluation of human TB vaccines.
di: O'Shea, M, et al.
Pubblicazione: (2016)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
di: Vordermeier, H, et al.
Pubblicazione: (2011)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
di: Tanner, R, et al.
Pubblicazione: (2021)

Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine Tuberculosis, (vol 77, pg 3371, 2009)
di: Vordermeier, H, et al.
Pubblicazione: (2011)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
di: Rachel Tanner, et al.
Pubblicazione: (2021-01-01)

Immunological mechanisms of tuberculosis susceptibility in TB-infected individuals with type 2 diabetes mellitus: insights from mycobacterial growth inhibition assay and cytokine analysis
di: Bindu Dasan, et al.
Pubblicazione: (2025-01-01)

Progress and challenges in TB vaccine development
di: Voss, G, et al.
Pubblicazione: (2018)

Human hookworm infection enhances mycobacterial growth inhibition and associates with reduced risk of tuberculosis infection
di: O'Shea, M, et al.
Pubblicazione: (2018)

Need for more TB vaccine field sites.
di: Mcshane, H
Pubblicazione: (2009)